Vimarsana
Biggest News Aggregation in the World

Page 11 - Allo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allo Today - Breaking & Trending Today

Allogene Therapeutics (NASDAQ:ALLO) Coverage Initiated by Analysts at Citigroup - Vimarsana News

Allogene Therapeutics (NASDAQ:ALLO) Coverage Initiated by Analysts at Citigroup

Citigroup started coverage on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a research note released on Friday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $7.00 target price on the stock. ALLO has been the topic of a number of other research reports. JPMorgan Chase & Co. cut their […]

Insider Sell Alert: CFO James Rallo Sells 5,000 Shares of Xometry Inc (XMTR) - Vimarsana News

Insider Sell Alert: CFO James Rallo Sells 5,000 Shares of Xometry Inc (XMTR)

In the dynamic world of stock market transactions, insider selling can often provide investors with valuable insights into a company's financial health and future prospects.

Source: yahoo.com
Learning STEM with Puzzles, Games and more! - Vimarsana News

Learning STEM with Puzzles, Games and more!

Thank you Learning Curve sponsors:Allo CommunicationsKearney Public SchoolsB/D Construction

Allogene Therapeutics (ALLO) Scheduled to Post Quarterly Earnings on Thursday - Vimarsana News

Allogene Therapeutics (ALLO) Scheduled to Post Quarterly Earnings on Thursday

Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) will be announcing its earnings results after the market closes on Thursday, November 2nd. Analysts expect the company to announce earnings of ($0.53) per share for the quarter. Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) last posted its earnings results on Wednesday, August 2nd. The company reported ($0.53) […]

Source: wkrb13.com
Allogene Therapeutics (NASDAQ:ALLO) Reaches New 12-Month Low at $2.88 - Vimarsana News

Allogene Therapeutics (NASDAQ:ALLO) Reaches New 12-Month Low at $2.88

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $2.88 and last traded at $3.03, with a volume of 486164 shares changing hands. The stock had previously closed at $3.08. Analysts Set New Price Targets A number of brokerages […]